Old Web
English
Sign In
Acemap
>
Paper
>
IDO in MDS/AML disease progression and its role in resistance to azacitidine: a potential new drug target?
IDO in MDS/AML disease progression and its role in resistance to azacitidine: a potential new drug target?
2020
Michael Leisch
Richard Greil
Lisa Pleyer
Keywords:
drug target
disease progression
Medicine
Internal medicine
Oncology
Azacitidine
Immunology
Diabetes mellitus
Correction
Source
Cite
Save
Machine Reading By IdeaReader
36
References
1
Citations
NaN
KQI
[]